INTENDED
nasal in antigens virus B influenza and antigens virus A influenza detect To help to (swab pharyngeal or mucus nasal/discharge nasal, swab nasal, aspirate.(illness infectious virus influenza of prognosis the in TEST THE OF EXPLANATION AND SUMMARY Three about in ensuing, epidemics seasonal in world the round spreads Influenza annual 000,650 to 000,290 about and sickness extreme of circumstances annual million 5 to (2017, Release News WHO. (years pandemic some in hundreds of thousands to rising, deaths ,headache, pains muscle, throat sore, fever, chills are signs Common.discomfort common and fatigue/weak spot, coughing these to related be can signs preliminary the as a result of troublesome is Diagnosis.

capilia TB-Neo

capilia TB-Neo

brokers infectious different by induced most the with related is and prevalent extra normally is virus A influenza The extra current normally infections B influenza whereas, epidemics influenza severe.signs gentle and prognosis speedy, contagious extremely is virus influenza the Because means the And. well being public on impact constructive a have can remedy immediate an prescribe to doctor the assistance can antigens B or A between distinguish to .remedy antiviral applicable
is onset symptom of hours 48 inside remedy antiviral of Administration
.shedding viral cut back to and signs of discount speedy extra for advisable or/and A influenza of detection correct and speedy present can Neo Flu Capilia tools or devices particular No. sufferers symptomatic from antigens virus B .required a

capilia TB-Neo

capilia TB-Neo

Description:

INTENDED USE

To detect influenza A virus antigens and influenza B virus antigens in nasal aspirate, nasal swab, nasal discharge/nasal mucus or pharyngeal swab (to help within the prognosis of influenza virus infectious illness).

SUMMARY AND EXPLANATION OF THE TEST

Influenza spreads world wide in seasonal epidemics, leading to about Three to five million annual circumstances of extreme sickness and about 290,000 to 650,000 annual deaths, rising to hundreds of thousands in some pandemic years. (WHO News Release, 2017)

Common signs are chills, fever, sore throat, muscle pains, headache, coughing, weak spot/fatigue and common discomfort.

Diagnosis is troublesome as a result of the preliminary signs may be much like these brought on by different infectious brokers.

The influenza A virus is normally extra prevalent and is related to essentially the most severe influenza epidemics, whereas influenza B infections normally current extra gentle signs.

Because the influenza virus is extremely contagious, speedy prognosis and immediate remedy can have a constructive impact on public well being. And the flexibility to differentiate between A or B antigens may help the doctor to prescribe an applicable antiviral remedy.

Administration of antiviral remedy inside 48 hours of symptom onset is advisable for extra speedy discount of signs and to cut back viral shedding.

Capilia Flu Neo can present speedy and correct detection of influenza A and/or B virus antigens from symptomatic sufferers. No particular devices or tools are required.

  • Provides quick and dependable outcomes
  • Easy to learn
  • Created via the newest nanotechnology “Platinum-Gold Colloid”
  • Includes an extraction buffer that’s suitable with Capilia 1 sequence assessments (Flu, Adeno, hMPV, RSV)

REAGENTS AND MATERIALS PROVIDED

  • Test cartridges
  • Extraction buffer (suitable with four totally different assessments)
  • Drip suggestions
  • Nasal swab

REPORTING TIME

3-5 minutes

PRINCIPLE OF THE TEST

Measurement utilizing this product is predicated on an immunochromatography assay utilizing a monoclonal antibody that acknowledges influenza virus antigens.

This product includes a check plate with a provider strip containing a pattern placement space, a reagent space together with a colloidal platinum-gold labeled anti-influenza A and B virus monoclonal antibody (mouse) (hereinafter known as “colloidal platinum-gold labeled antibody” ), a studying space [A] that fixes the anti-influenza A virus monoclonal antibody (mouse) (hereinafter known as “anti-influenza A virus antibody” ), a studying space [B] that fixes the anti-influenza B virus monoclonal antibody (mouse) (hereinafter known as “anti-influenza B virus antibody” ), and a studying space [C] that fixes the anti-mouse immunoglobulin polyclonal antibody (rabbit) (hereinafter known as “anti-mouse immunoglobulin antibody” ).

Capilia tb ag

Capilia tb ag

Product Summary

  • Kit contents :
    Test Plate×10, Extraction Buffer 0.7mL×10, Nozzle×10, Nasal Swab×10
  • Validity  27 months
  • Storage  retailer at 2-30℃
  • Detection time  3-5 minutes
  • Positive Control (Sold Separately)
    Kit contents: Positive Control Flu A 1.0mL 1vial, Positive Control Flu B 1.0mL 1vial
  • Validity 12 months
  • Storage Store at 2-8℃
  • Positive Control Flu Procedure

rtTA (Neo) , Lentiviral particles

LVP400-Neo 1x107 IFU/ml x 200ul
EUR 404
Description: Pre-made lentiviral particles expressing reverse tetracycline Transcriptional Activator (rtTA) under enhanced EF1a promoter with Neomycin antibioic marker, provided in DMEM medium with 10% FBS.

CMV-TetR (Neo) Lentiviral particles 

LVP017-Neo 1x107 IFU/ml x 200ul
EUR 404
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under CMV promoter, with Neomycin antibiotic marker.

β-Lactamase (Neo) lentiviral particles

LVP335-Neo 1x107 IFU/ml x 200ul
EUR 349
Description: pre-made lentiviral particles expressing β-Lactamase gene. A Neomycin marker was expressed under RSV promoter. Particles is provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

EF1a-TetR (Neo) Lentiviral particles 

LVP459-Neo 1x107 IFU/ml x 200ul
EUR 404
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under enhanced EF1a promoter with Neomycin antibioic marker.

LoxP GFP/RFP ColorSwitch (Neo) lentivirus

LVP460-Neo 1x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing "LoxP-GFP-stop-LoxP-RFP-Stop" cassette under suCMV promoter. It also contains a Neomycin antibiotic selection marker under Rsv promoter. Virus is provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

pWZL-Neo Retroviral Vector

RTV-001-NEO 10 ?g
EUR 566
Description: Use this construct to clone your gene for downstream recombinant retroviral packaging

SV40 large T-antigen (Neo), CMV lentiviral particles

LVP016-Neo 1x107 IFU/ml x 200ul
EUR 349
Description: Pre-made lentiviral particles expressing SV40 large T-antigen under suCMV promoter, containing Neomycin marker.

SV40 large T-antigen (Neo), EF1a lentiviral particles

LVP557-Neo 1x107 IFU/ml x 200ul
EUR 349
Description: Pre-made lentiviral particles expressing SV40 large T-antigen under EF1a promoter, containing Neomycin marker.

EF1a Control lentiviral particles (Neo)

EF1a-Null-Neo 1 x107 IFU/ml x 200ul
EUR 349
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter.

CMV Control lentiviral particles (Neo)

CMV-Null-Neo 1 x107 IFU/ml x 200ul
EUR 349
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter.

hTERT (CMV, Neo) lentivirus in PBS

LVP1130-Neo-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Concentrated lentivirus in PBS, expressing human TERT gene under suCMV promoter, containing Neomycin marker.

hTERT (EF1a, Neo) lentivirus in PBS

LVP1131-Neo-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Concentrated lentivirus in PBS, expressing human TERT gene under EF1a promoter, containing Neomycin marker.

rtTA (Neo) in PBS, Lentiviral particles

LVP400-Neo-PBS 5x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles expressing reverse tetracycline Transcriptional Activator (rtTA) under enhanced EF1a promoter with Neomycin antibioic marker, concentrated particles provided in PBS solution.

Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP Neo)

SC018-Neo 2x10E6 cell/ml x1ml
EUR 4400
Description: CRE reporter cell line (Neo): HEK293 cell line expressing "LoxP-GFP-stop-LoxP-RFP" cassette with Neomycin antibiotic marker

CMV-TetR (Neo) Lentiviral particles  in PBS

LVP017-Neo-PBS 5x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under CMV promoter, with Neomycin antibiotic marker. Particles pellet was re-suspended in PBS solution.

EF1a-TetR (Neo) Lentiviral particles  in PBS

LVP459-Neo-PBS 5x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under enhanced EF1a promoter with Neomycin antibioic marker. Particles was pellet down and re-suspended in PBS solution.

LoxP GFP/RFP ColorSwitch (Neo) lentivirus (concentrated)

LVP460-Neo-PBS 5x107 IFU/ml x 200ul
EUR 862
Description: Pre-made lentiviral particles expressing "LoxP-GFP-stop-LoxP-RFP-Stop" cassette under suCMV promoter. It also contains a Neomycin antibiotic selection marker under Rsv promoter. Virus was provied in PBS solution.